Distinct Cerebrovascular Reactivity Patterns for Brain Radiation Necrosis
暂无分享,去创建一个
M. Weller | M. Piccirelli | N. Andratschke | L. Regli | C. V. van Niftrik | J. Fierstra | M. Sebök | K. Seystahl | G. Muscas | Michelle L. Brown | A. Della Puppa | Martina Sebök
[1] M. Weller,et al. Hemodynamic investigation of peritumoral impaired blood oxygenation-level dependent cerebrovascular reactivity in patients with diffuse glioma. , 2020, Magnetic resonance imaging.
[2] D. Mikulis,et al. Magnetic Resonance Imaging–Based Cerebrovascular Reactivity and Hemodynamic Reserve: A Review of Method Optimization and Data Interpretation , 2018, Stroke.
[3] P. Delgado-López,et al. Treatment-related changes in glioblastoma: a review on the controversies in response assessment criteria and the concepts of true progression, pseudoprogression, pseudoresponse and radionecrosis , 2018, Clinical and Translational Oncology.
[4] M. Glas,et al. 11C–MET PET/MRI for detection of recurrent glioma , 2018, European Journal of Nuclear Medicine and Molecular Imaging.
[5] Mukesh Kumar,et al. Differentiation of Recurrent/Residual Glioma From Radiation Necrosis Using Semi Quantitative 99mTc MDM (Bis-Methionine-DTPA) Brain SPECT/CT and Dynamic Susceptibility Contrast-Enhanced MR Perfusion: A Comparative Study , 2018, Clinical nuclear medicine.
[6] Marco Piccirelli,et al. Impact of baseline CO2 on Blood-Oxygenation-Level-Dependent MRI measurements of cerebrovascular reactivity and task-evoked signal activation. , 2018, Magnetic resonance imaging.
[7] A. Luft,et al. Staging Hemodynamic Failure With Blood Oxygen-Level–Dependent Functional Magnetic Resonance Imaging Cerebrovascular Reactivity: A Comparison Versus Gold Standard (15O-)H2O-Positron Emission Tomography , 2018, Stroke.
[8] Paolo Vitali,et al. Brain Gliomas: Multicenter Standardized Assessment of Dynamic Contrast-enhanced and Dynamic Susceptibility Contrast MR Images. , 2018, Radiology.
[9] Karl-Josef Langen,et al. PET Imaging in Glioblastoma: Use in Clinical Practice , 2017 .
[10] A. Luft,et al. Iterative analysis of cerebrovascular reactivity dynamic response by temporal decomposition , 2017, Brain and behavior.
[11] Rebecca W. Pak,et al. Implications of neurovascular uncoupling in functional magnetic resonance imaging (fMRI) of brain tumors , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[12] Nadim Jon Shah,et al. Advances in neuro-oncology imaging , 2017, Nature Reviews Neurology.
[13] L. Denaro,et al. Effectiveness of antiangiogenic drugs in glioblastoma patients: A systematic review and meta-analysis of randomized clinical trials. , 2017, Critical reviews in oncology/hematology.
[14] Marco Piccirelli,et al. Altered intraoperative cerebrovascular reactivity in brain areas of high-grade glioma recurrence. , 2016, Magnetic resonance imaging.
[15] Kyung K Peck,et al. Vascular Reactivity Maps in Patients with Gliomas Using Breath‐Holding BOLD fMRI , 2016, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[16] Shruti Agarwal,et al. Neurovascular uncoupling in resting state fMRI demonstrated in patients with primary brain gliomas , 2016, Journal of magnetic resonance imaging : JMRI.
[17] Chien-Kuo Wang,et al. Differentiating Radiation-Induced Necrosis from Recurrent Brain Tumor Using MR Perfusion and Spectroscopy: A Meta-Analysis , 2016, PloS one.
[18] David J Mikulis,et al. Assessing the effect of unilateral cerebral revascularisation on the vascular reactivity of the non-intervened hemisphere: a retrospective observational study , 2015, BMJ Open.
[19] D J Mikulis,et al. Cerebrovascular Reactivity Mapping: An Evolving Standard for Clinical Functional Imaging , 2015, American Journal of Neuroradiology.
[20] Qun Wang,et al. Role of magnetic resonance spectroscopy for the differentiation of recurrent glioma from radiation necrosis: a systematic review and meta-analysis. , 2014, European journal of radiology.
[21] J. D. de Groot,et al. Antiangiogenic Therapy for Glioblastoma: Current Status and Future Prospects , 2014, Clinical Cancer Research.
[22] C. Destrieux,et al. Radionecrosis of malignant glioma and cerebral metastasis: a diagnostic challenge in MRI. , 2014, Diagnostic and interventional imaging.
[23] D. Rigamonti,et al. Postradiation imaging changes in the CNS: how can we differentiate between treatment effect and disease progression? , 2014, Future oncology.
[24] D J Mikulis,et al. Measuring cerebrovascular reactivity: what stimulus to use? , 2013, The Journal of physiology.
[25] Surjith Vattoth,et al. Radiation necrosis in the brain: imaging features and differentiation from tumor recurrence. , 2012, Radiographics : a review publication of the Radiological Society of North America, Inc.
[26] Jay J Pillai,et al. Comparison of BOLD Cerebrovascular Reactivity Mapping and DSC MR Perfusion Imaging for Prediction of Neurovascular Uncoupling Potential in Brain Tumors , 2012, Technology in cancer research & treatment.
[27] Mitchel S Berger,et al. Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging. , 2012, Neuro-oncology.
[28] Y. Yamada,et al. Radiation necrosis following treatment of high grade glioma—a review of the literature and current understanding , 2012, Acta Neurochirurgica.
[29] Jay J Pillai,et al. Clinical utility of cerebrovascular reactivity mapping in patients with low grade gliomas. , 2011, World journal of clinical oncology.
[30] Jun Hua,et al. Cerebrovascular reactivity mapping for brain tumor presurgical planning. , 2011, World journal of clinical oncology.
[31] D. Attwell,et al. Glial and neuronal control of brain blood flow , 2022 .
[32] David J Mikulis,et al. Impaired Cerebrovascular Reactivity With Steal Phenomenon Is Associated With Increased Diffusion in White Matter of Patients With Moyamoya Disease , 2010, Stroke.
[33] P. Wen,et al. Antiangiogenic therapies for high-grade glioma , 2009, Nature Reviews Neurology.
[34] H. Amthauer,et al. 123I-IMT SPECT and 1HMR-Spectroscopy at 3.0T in the Differential Diagnosis of Recurrent or Residual Gliomas: A Comparative Study , 2004, Journal of Neuro-Oncology.
[35] T. Mikkelsen,et al. Associations among Magnetic Resonance Spectroscopy, Apparent Diffusion Coefficients, and Image-Guided Histopathology with Special Attention to Radiation Necrosis , 2004, Neurosurgery.
[36] W P Dillon,et al. Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. , 2001, AJNR. American journal of neuroradiology.
[37] J A Maldjian,et al. The effect of brain tumors on BOLD functional MR imaging activation in the adjacent motor cortex: implications for image-guided neurosurgery. , 2000, AJNR. American journal of neuroradiology.
[38] M Takahashi,et al. Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. , 2000, AJNR. American journal of neuroradiology.
[39] J A Maldjian,et al. Decreased BOLD functional MR activation of the motor and sensory cortices adjacent to a glioblastoma multiforme: implications for image-guided neurosurgery. , 1999, AJNR. American journal of neuroradiology.
[40] M. Weller,et al. Diffuse gliomas exhibit whole brain impaired cerebrovascular reactivity. , 2018, Magnetic resonance imaging.